More Immutep Ltd news Immutep LtdASX: IMM Update on Phase I Study of IMP761 for Autoimmune Diseases Mar 19, 2026 at 1:41 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
